BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 2483768)

  • 41. Plasma protein profiles and prognosis in gastric cancer.
    Rashid SA; O'Quigley J; Axon AT; Cooper EH
    Br J Cancer; 1982 Mar; 45(3):390-4. PubMed ID: 6896153
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute-phase plasma proteins in gastric cancer: association with metastatic potential and prognosis.
    Ogoshi K; Tajima T; Mitomi T; Tsuda M; Yamamura M
    Tumour Biol; 1996; 17(5):281-9. PubMed ID: 8792854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The isoelectric focusing pattern of desialylated alpha 1-antichymotrypsin of heterozygous alpha 1-antichymotrypsin deficiency and of acute phase plasma.
    Lindmark B; Kamiguchi H; Tsuda M; Yamamura M
    Tokai J Exp Clin Med; 1990 Jul; 15(4):347-51. PubMed ID: 2130541
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Glycosidically bound sialic acid levels as a predictive marker of postoperative adjuvant therapy in gastric cancer.
    Ogoshi K; Kondoh Y; Tajima T; Mitomi T
    Cancer Immunol Immunother; 1992; 35(3):175-80. PubMed ID: 1638553
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Possible predictive markers of immunotherapy in esophageal cancer: retrospective analysis of a randomized study. The Cooperative Study Group for Esophageal Cancer in Japan.
    Ogoshi K; Satou H; Isono K; Mitomi T; Endoh M; Sugita M
    Cancer Invest; 1995; 13(4):363-9. PubMed ID: 7627722
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes of acute phase proteins glycosylation profile as a possible prognostic marker in myocardial infarction.
    Kaźmierczak M; Sobieska M; Wiktorowicz K; Wysocki H
    Int J Cardiol; 1995 May; 49(3):201-7. PubMed ID: 7544326
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The levels of alpha 1-antitrypsin and alpha 1-antichymotrypsin in the sera of patients with gastrointestinal cancers during diagnosis.
    Bernacka K; Kuryliszyn-Moskal A; Sierakowski S
    Cancer; 1988 Sep; 62(6):1188-93. PubMed ID: 3261623
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The clinical value of acute phase reactant measurements in thermal injury.
    Barrett M
    Scand J Plast Reconstr Surg Hand Surg; 1987; 21(3):293-5. PubMed ID: 2450399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acute-phase reactants as tumor markers.
    Schwartz MK
    Cancer Invest; 1995; 13(4):444-5. PubMed ID: 7543001
    [No Abstract]   [Full Text] [Related]  

  • 50. Serological alpha 1-antichymotrypsin in patients with probable senile dementia of Alzheimer type: a short-term longitudinal study.
    Licastro F; Davis LJ; Polazzi E; Rossi S; Cucinotta D
    Alzheimer Dis Assoc Disord; 1996; 10(4):192-6. PubMed ID: 8939278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum protein changes after abdominal surgery.
    Shakespeare PG; Ball AJ; Spurr ED
    Ann Clin Biochem; 1989 Jan; 26 ( Pt 1)():49-57. PubMed ID: 2472099
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute phase reactants in nondomesticated mammals-A veterinary clinical pathology perspective.
    Hooijberg EH; Cray C
    Vet Clin Pathol; 2023 Feb; 52 Suppl 1():19-36. PubMed ID: 36289012
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The acute phase protein profile in inflammatory arthropathies.
    Lapadula G; Numo R
    Scand J Rheumatol Suppl; 1987; 65():90-3. PubMed ID: 2446383
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Types of acute phase reactants and their importance in vaccination.
    Khalil RH; Al-Humadi N
    Biomed Rep; 2020 Apr; 12(4):143-152. PubMed ID: 32190302
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The prognostic significance of pretreatment serum CEA levels in gastric cancer: a meta-analysis including 14651 patients.
    Deng K; Yang L; Hu B; Wu H; Zhu H; Tang C
    PLoS One; 2015; 10(4):e0124151. PubMed ID: 25879931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concentrations of alpha-1-antichymotrypsin and other acute phase reactants in patients with gastric cancer.
    Ogoshi K; Iwata Y; Hara S; Kondoh Y; Nakazaki H; Tajima T; Mitomi T
    Tokai J Exp Clin Med; 1988 Dec; 13(6):355-60. PubMed ID: 2483768
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunotherapy and combined assay of serum levels of carcinoembryonic antigen and acute-phase reactants.
    Ogoshi K; Miyaji M; Nakamura K; Kondoh Y; Makuuchi H; Tajima T
    Cancer Immunol Immunother; 1998 Mar; 46(1):14-20. PubMed ID: 9520287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
    Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Multivariate analysis of the prognostic value of CEA and CA 19-9 serum levels in colorectal cancer.
    Reiter W; Stieber P; Reuter C; Nagel D; Lau-Werner U; Lamerz R
    Anticancer Res; 2000; 20(6D):5195-8. PubMed ID: 11326694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Selection of adjuvant chemotherapy for gastric cancer using objective criteria.
    Nishiyama M; Toge T
    Gan To Kagaku Ryoho; 1997 May; 24 Suppl 1():232-8. PubMed ID: 9210903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.